NEWS

Alliance Foundation Trials Study Finds Combination Hormonal Therapy Delivered in Finite Period Improves PSA Levels in Patients with Prostate Cancer

September 10, 2022

Boston, MA – The Alliance Foundation Trials, LLC (AFT) will present data from PRESTO (AFT-19), the first trial to evaluate if intensifying the treatment beyond androgen deprivation therapy (ADT) by adding apalutamide with or without abiraterone acetate plus prednisone for a finite period will prolong disease progre


Alliance for Clinical Trials in Oncology Applauds Appointment of Monica M. Bertagnolli as NCI's New Director

August 10, 2022

CHICAGO, IL (August 10, 2022) - The Alliance for Clinical Trials in Oncology applauds the appointment of its Group Chair and President of the Alliance for Clinical Trials in Oncology Foundation Monica M. Bertagnolli, MD, FACS, FASCO, to serve as President Joe Biden’s pick for Director of the N


SITC Clinical Immuno-Oncology Network (SCION) Workshop | January 2023

August 8, 2022

An Intimate Cancer Immunotherapy Clinical Trial Protocol Development Program

The Society for Immunotherapy of Cancer (SITC) Clinical Immuno-Oncology Network (SCION) Workshop is an intimate immunotherapy clinical trial development program, led by experts in the field who are equipped to help their assigned students navigate through the unique considerations that accompany immunotherapy treatments.


Older News